Toll Free: 1-888-928-9744

EMEA (Europe, Middle East and Africa) Polio Vaccines Industry 2017 Market Research Report

Published: Nov, 2017 | Pages: 105 | Publisher: QYResearch
Industry: Pharmaceutical | Report Format: Electronic (PDF)

In this report, the EMEA Polio Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Polio Vaccines for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Polio Vaccines market competition by top manufacturers/players, with Polio Vaccines sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Astellas Pharma
    CSL
    Emergent BioSolutions
    GlaxoSmithKline
    Johnson & Johnson
    MedImmune
    Merck
    Pfizer
    Sanofi Pasteur
    Serum Institute

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    IPV (Inactivated Poliovirus Vaccine)
    OPV (Oral Polio Vaccine)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Age (0-1)
    Age Above 1

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

EMEA (Europe, Middle East and Africa) Polio Vaccines Market Report 2017
1 Polio Vaccines Overview
    1.1 Product Overview and Scope of Polio Vaccines
    1.2 Classification of Polio Vaccines
        1.2.1 EMEA Polio Vaccines Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Polio Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 IPV (Inactivated Poliovirus Vaccine)
        1.2.4 OPV (Oral Polio Vaccine)
    1.3 EMEA Polio Vaccines Market by Application/End Users
        1.3.1 EMEA Polio Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Age (0-1)
        1.3.3 Age Above 1
    1.4 EMEA Polio Vaccines Market by Region
        1.4.1 EMEA Polio Vaccines Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Polio Vaccines (2012-2022)
        1.5.1 EMEA Polio Vaccines Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Polio Vaccines Revenue and Growth Rate (2012-2022)

2 EMEA Polio Vaccines Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Polio Vaccines Market Competition by Players/Manufacturers
        2.1.1 EMEA Polio Vaccines Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Polio Vaccines Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Polio Vaccines Sale Price by Players (2012-2017)
    2.2 EMEA Polio Vaccines (Volume and Value) by Type/Product Category
        2.2.1 EMEA Polio Vaccines Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Polio Vaccines Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Polio Vaccines Sale Price by Type (2012-2017)
    2.3 EMEA Polio Vaccines (Volume) by Application
    2.4 EMEA Polio Vaccines (Volume and Value) by Region
        2.4.1 EMEA Polio Vaccines Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Polio Vaccines Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Polio Vaccines Sales Price by Region (2012-2017)

3 Europe Polio Vaccines (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Polio Vaccines Sales and Value (2012-2017)
        3.1.1 Europe Polio Vaccines Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Polio Vaccines Revenue and Growth Rate (2012-2017)
    3.2 Europe Polio Vaccines Sales and Market Share by Type
    3.3 Europe Polio Vaccines Sales and Market Share by Application
    3.4 Europe Polio Vaccines Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Polio Vaccines Sales Volume by Countries (2012-2017)
        3.4.2 Europe Polio Vaccines Revenue by Countries (2012-2017)
        3.4.3 Germany Polio Vaccines Sales and Growth Rate (2012-2017)
        3.4.4 France Polio Vaccines Sales and Growth Rate (2012-2017)
        3.4.5 UK Polio Vaccines Sales and Growth Rate (2012-2017)
        3.4.6 Russia Polio Vaccines Sales and Growth Rate (2012-2017)
        3.4.7 Italy Polio Vaccines Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Polio Vaccines Sales and Growth Rate (2012-2017)

4 Middle East Polio Vaccines (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Polio Vaccines Sales and Value (2012-2017)
        4.1.1 Middle East Polio Vaccines Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Polio Vaccines Revenue and Growth Rate (2012-2017)
    4.2 Middle East Polio Vaccines Sales and Market Share by Type
    4.3 Middle East Polio Vaccines Sales and Market Share by Application
    4.4 Middle East Polio Vaccines Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Polio Vaccines Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Polio Vaccines Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Polio Vaccines Sales and Growth Rate (2012-2017)
        4.4.4 Israel Polio Vaccines Sales and Growth Rate (2012-2017)
        4.4.5 UAE Polio Vaccines Sales and Growth Rate (2012-2017)
        4.4.6 Iran Polio Vaccines Sales and Growth Rate (2012-2017)

5 Africa Polio Vaccines (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Polio Vaccines Sales and Value (2012-2017)
        5.1.1 Africa Polio Vaccines Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Polio Vaccines Revenue and Growth Rate (2012-2017)
    5.2 Africa Polio Vaccines Sales and Market Share by Type
    5.3 Africa Polio Vaccines Sales and Market Share by Application
    5.4 Africa Polio Vaccines Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Polio Vaccines Sales Volume by Countries (2012-2017)
        5.4.2 Africa Polio Vaccines Revenue by Countries (2012-2017)
        5.4.3 South Africa Polio Vaccines Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Polio Vaccines Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Polio Vaccines Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Polio Vaccines Sales and Growth Rate (2012-2017)

6 EMEA Polio Vaccines Manufacturers/Players Profiles and Sales Data
    6.1 Astellas Pharma
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Polio Vaccines Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Astellas Pharma Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 CSL
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Polio Vaccines Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 CSL Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Emergent BioSolutions
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Polio Vaccines Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Emergent BioSolutions Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 GlaxoSmithKline
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Polio Vaccines Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 GlaxoSmithKline Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Johnson & Johnson
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Polio Vaccines Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Johnson & Johnson Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 MedImmune
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Polio Vaccines Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 MedImmune Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Merck
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Polio Vaccines Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Merck Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Pfizer
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Polio Vaccines Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Pfizer Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Sanofi Pasteur
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Polio Vaccines Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Sanofi Pasteur Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Serum Institute
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Polio Vaccines Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Serum Institute Polio Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Polio Vaccines Manufacturing Cost Analysis
    7.1 Polio Vaccines Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Polio Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Polio Vaccines Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Polio Vaccines Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Polio Vaccines Market Forecast (2017-2022)
    11.1 EMEA Polio Vaccines Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Polio Vaccines Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Polio Vaccines Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Polio Vaccines Price and Trend Forecast (2017-2022)
    11.2 EMEA Polio Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Polio Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Polio Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Polio Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Polio Vaccines Sales Forecast by Type (2017-2022)
    11.7 EMEA Polio Vaccines Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer


List of Tables and Figures

    Figure Product Picture of Polio Vaccines
    Figure EMEA Polio Vaccines Sales Volume (K Units) by Type (2012-2022)
    Figure EMEA Polio Vaccines Sales Volume Market Share by Type (Product Category) in 2016
    Figure IPV (Inactivated Poliovirus Vaccine) Product Picture
    Figure OPV (Oral Polio Vaccine) Product Picture
    Figure EMEA Polio Vaccines Sales Volume (K Units) by Application (2012-2022)
    Figure EMEA Sales Market Share of Polio Vaccines by Application in 2016
    Figure Age (0-1) Examples
    Table Key Downstream Customer in Age (0-1)
    Figure Age Above 1 Examples
    Table Key Downstream Customer in Age Above 1
    Figure EMEA Polio Vaccines Market Size (Million USD) by Region (2012-2022)
    Figure Europe Polio Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Europe Polio Vaccines Revenue (Million USD) Status and Forecast by Countries
    Figure Middle East Polio Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Middle East Polio Vaccines Revenue (Million USD) Status and Forecast by Countries
    Figure Africa Polio Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Africa Polio Vaccines Revenue (Million USD) Status and Forecast by Countries
    Figure EMEA Polio Vaccines Sales Volume and Growth Rate (2012-2022)
    Figure EMEA Polio Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
    Figure EMEA Polio Vaccines Market Major Players Product Sales Volume (K Units) (2012-2017)
    Table EMEA Polio Vaccines Sales Volume (K Units) of Major Players (2012-2017)
    Table EMEA Polio Vaccines Sales Share by Players (2012-2017)
    Figure 2016 Polio Vaccines Sales Share by Players
    Figure 2017 Polio Vaccines Sales Share by Players
    Figure EMEA Polio Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
    Table EMEA Polio Vaccines Revenue (Million USD) by Players (2012-2017)
    Table EMEA Polio Vaccines Revenue Share by Players (2012-2017)
    Table 2016 EMEA Polio Vaccines Revenue Share by Players
    Table 2017 EMEA Polio Vaccines Revenue Share by Players
    Table EMEA Polio Vaccines Sale Price (USD/Unit) by Players (2012-2017)
    Table EMEA Polio Vaccines Sales (K Units) and Market Share by Type (2012-2017)
    Table EMEA Polio Vaccines Sales Share by Type (2012-2017)
    Figure Sales Market Share of Polio Vaccines by Type (2012-2017)
    Figure EMEA Polio Vaccines Sales Market Share by Type (2012-2017)
    Table EMEA Polio Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
    Table EMEA Polio Vaccines Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Polio Vaccines by Type in 2016
    Table EMEA Polio Vaccines Sale Price (USD/Unit) by Type (2012-2017)
    Table EMEA Polio Vaccines Sales (K Units) and Market Share by Application (2012-2017)
    Table EMEA Polio Vaccines Sales Share by Application (2012-2017)
    Figure Sales Market Share of Polio Vaccines by Application (2012-2017)
    Figure EMEA Polio Vaccines Sales Market Share by Application in 2016
    Table EMEA Polio Vaccines Sales (K Units) and Market Share by Region (2012-2017)
    Table EMEA Polio Vaccines Sales Share by Region (2012-2017)
    Figure Sales Market Share of Polio Vaccines by Region (2012-2017)
    Figure EMEA Polio Vaccines Sales Market Share in 2016
    Table EMEA Polio Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
    Table EMEA Polio Vaccines Revenue Share by Region (2012-2017)
    Figure Revenue Market Share of Polio Vaccines by Region (2012-2017)
    Figure EMEA Polio Vaccines Revenue Market Share Regions in 2016
    Table EMEA Polio Vaccines Sales Price (USD/Unit) by Region (2012-2017)
    Figure Europe Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Europe Polio Vaccines Revenue and Growth Rate (2012-2017)
    Table Europe Polio Vaccines Sales (K Units) by Type (2012-2017)
    Table Europe Polio Vaccines Market Share by Type (2012-2017)
    Figure Europe Polio Vaccines Market Share by Type in 2016
    Table Europe Polio Vaccines Sales (K Units) by Application (2012-2017)
    Table Europe Polio Vaccines Market Share by Application (2012-2017)
    Figure Europe Polio Vaccines Market Share by Application in 2016
    Table Europe Polio Vaccines Sales (K Units) by Countries (2012-2017)
    Table Europe Polio Vaccines Sales Market Share by Countries (2012-2017)
    Figure Europe Polio Vaccines Sales Market Share by Countries (2012-2017)
    Figure Europe Polio Vaccines Sales Market Share by Countries in 2016
    Table Europe Polio Vaccines Revenue (Million USD) by Countries (2012-2017)
    Table Europe Polio Vaccines Revenue Market Share by Countries (2012-2017)
    Figure Europe Polio Vaccines Revenue Market Share by Countries (2012-2017)
    Figure Europe Polio Vaccines Revenue Market Share by Countries in 2016
    Figure Germany Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure France Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure UK Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Russia Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Italy Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Benelux Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Middle East Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Middle East Polio Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
    Table Middle East Polio Vaccines Sales (K Units) by Type (2012-2017)
    Table Middle East Polio Vaccines Market Share by Type (2012-2017)
    Figure Middle East Polio Vaccines Market Share by Type (2012-2017)
    Table Middle East Polio Vaccines Sales (K Units) by Applications (2012-2017)
    Table Middle East Polio Vaccines Market Share by Applications (2012-2017)
    Figure Middle East Polio Vaccines Sales Market Share by Application in 2016
    Table Middle East Polio Vaccines Sales Volume (K Units) by Countries (2012-2017)
    Table Middle East Polio Vaccines Sales Volume Market Share by Countries (2012-2017)
    Figure Middle East Polio Vaccines Sales Volume Market Share by Countries in 2016
    Table Middle East Polio Vaccines Revenue (Million USD) by Countries (2012-2017)
    Table Middle East Polio Vaccines Revenue Market Share by Countries (2012-2017)
    Figure Middle East Polio Vaccines Revenue Market Share by Countries (2012-2017)
    Figure Middle East Polio Vaccines Revenue Market Share by Countries in 2016
    Figure Saudi Arabia Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Israel Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure UAE Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Iran Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Africa Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Africa Polio Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
    Table Africa Polio Vaccines Sales (K Units) by Type (2012-2017)
    Table Africa Polio Vaccines Sales Market Share by Type (2012-2017)
    Figure Africa Polio Vaccines Sales Market Share by Type (2012-2017)
    Figure Africa Polio Vaccines Sales Market Share by Type in 2016
    Table Africa Polio Vaccines Sales (K Units) by Application (2012-2017)
    Table Africa Polio Vaccines Sales Market Share by Application (2012-2017)
    Figure Africa Polio Vaccines Sales Market Share by Application (2012-2017)
    Table Africa Polio Vaccines Sales Volume (K Units) by Countries (2012-2017)
    Table Africa Polio Vaccines Sales Market Share by Countries (2012-2017)
    Figure Africa Polio Vaccines Sales Market Share by Countries (2012-2017)
    Figure Africa Polio Vaccines Sales Market Share by Countries in 2016
    Table Africa Polio Vaccines Revenue (Million USD) by Countries (2012-2017)
    Table Africa Polio Vaccines Revenue Market Share by Countries (2012-2017)
    Figure Africa Polio Vaccines Revenue Market Share by Countries (2012-2017)
    Figure Africa Polio Vaccines Revenue Market Share by Countries in 2016
    Figure South Africa Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Nigeria Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Egypt Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Algeria Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Table Astellas Pharma Polio Vaccines Basic Information List
    Table Astellas Pharma Polio Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Astellas Pharma Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Astellas Pharma Polio Vaccines Sales Market Share in EMEA (2012-2017)
    Figure Astellas Pharma Polio Vaccines Revenue Market Share in EMEA (2012-2017)
    Table CSL Polio Vaccines Basic Information List
    Table CSL Polio Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure CSL Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure CSL Polio Vaccines Sales Market Share in EMEA (2012-2017)
    Figure CSL Polio Vaccines Revenue Market Share in EMEA (2012-2017)
    Table Emergent BioSolutions Polio Vaccines Basic Information List
    Table Emergent BioSolutions Polio Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Emergent BioSolutions Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Emergent BioSolutions Polio Vaccines Sales Market Share in EMEA (2012-2017)
    Figure Emergent BioSolutions Polio Vaccines Revenue Market Share in EMEA (2012-2017)
    Table GlaxoSmithKline Polio Vaccines Basic Information List
    Table GlaxoSmithKline Polio Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure GlaxoSmithKline Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure GlaxoSmithKline Polio Vaccines Sales Market Share in EMEA (2012-2017)
    Figure GlaxoSmithKline Polio Vaccines Revenue Market Share in EMEA (2012-2017)
    Table Johnson & Johnson Polio Vaccines Basic Information List
    Table Johnson & Johnson Polio Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Johnson & Johnson Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Johnson & Johnson Polio Vaccines Sales Market Share in EMEA (2012-2017)
    Figure Johnson & Johnson Polio Vaccines Revenue Market Share in EMEA (2012-2017)
    Table MedImmune Polio Vaccines Basic Information List
    Table MedImmune Polio Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure MedImmune Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure MedImmune Polio Vaccines Sales Market Share in EMEA (2012-2017)
    Figure MedImmune Polio Vaccines Revenue Market Share in EMEA (2012-2017)
    Table Merck Polio Vaccines Basic Information List
    Table Merck Polio Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Merck Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Merck Polio Vaccines Sales Market Share in EMEA (2012-2017)
    Figure Merck Polio Vaccines Revenue Market Share in EMEA (2012-2017)
    Table Pfizer Polio Vaccines Basic Information List
    Table Pfizer Polio Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Pfizer Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Pfizer Polio Vaccines Sales Market Share in EMEA (2012-2017)
    Figure Pfizer Polio Vaccines Revenue Market Share in EMEA (2012-2017)
    Table Sanofi Pasteur Polio Vaccines Basic Information List
    Table Sanofi Pasteur Polio Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Sanofi Pasteur Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Sanofi Pasteur Polio Vaccines Sales Market Share in EMEA (2012-2017)
    Figure Sanofi Pasteur Polio Vaccines Revenue Market Share in EMEA (2012-2017)
    Table Serum Institute Polio Vaccines Basic Information List
    Table Serum Institute Polio Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Serum Institute Polio Vaccines Sales (K Units) and Growth Rate (2012-2017)
    Figure Serum Institute Polio Vaccines Sales Market Share in EMEA (2012-2017)
    Figure Serum Institute Polio Vaccines Revenue Market Share in EMEA (2012-2017)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Polio Vaccines
    Figure Manufacturing Process Analysis of Polio Vaccines
    Figure Polio Vaccines Industrial Chain Analysis
    Table Raw Materials Sources of Polio Vaccines Major Manufacturers in 2016
    Table Major Buyers of Polio Vaccines
    Table Distributors/Traders List
    Figure EMEA Polio Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
    Figure EMEA Polio Vaccines Revenue and Growth Rate Forecast (2017-2022)
    Figure EMEA Polio Vaccines Price (USD/Unit) and Trend Forecast (2017-2022)
    Table EMEA Polio Vaccines Sales (K Units) Forecast by Region (2017-2022)
    Figure EMEA Polio Vaccines Sales Market Share Forecast by Region (2017-2022)
    Table EMEA Polio Vaccines Revenue (Million USD) Forecast by Region (2017-2022)
    Figure EMEA Polio Vaccines Revenue Market Share Forecast by Region (2017-2022)
    Table Europe Polio Vaccines Sales (K Units) Forecast by Countries (2017-2022)
    Figure Europe Polio Vaccines Sales Market Share Forecast by Countries (2017-2022)
    Table Europe Polio Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Europe Polio Vaccines Revenue Market Share Forecast by Countries (2017-2022)
    Table Middle East Polio Vaccines Sales (K Units) Forecast by Countries (2017-2022)
    Figure Middle East Polio Vaccines Sales Market Share Forecast by Countries (2017-2022)
    Table Middle East Polio Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Middle East Polio Vaccines Revenue Market Share Forecast by Countries (2017-2022)
    Table Africa Polio Vaccines Sales (K Units) Forecast by Countries (2017-2022)
    Figure Africa Polio Vaccines Sales Market Share Forecast by Countries (2017-2022)
    Table Africa Polio Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Africa Polio Vaccines Revenue Market Share Forecast by Countries (2017-2022)
    Table EMEA Polio Vaccines Sales (K Units) Forecast by Type (2017-2022)
    Figure EMEA Polio Vaccines Sales Market Share Forecast by Type (2017-2022)
    Table EMEA Polio Vaccines Sales (K Units) Forecast by Application (2017-2022)
    Figure EMEA Polio Vaccines Sales Market Share Forecast by Application (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $4000
Multi User - US $8000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify